Imiglucerase is a key drug for the treatment of type 1 Gaucher disease, and its price has always been a concern for patients. In 2025, the price of imiglucerase has undergone certain adjustments. Patients also need to pay close attention to information about purchasing channels and medication precautions. The original research drug exported to Turkey by Sanofi, a French pharmaceutical company, with a specification of 400U/10ml, is priced at approximately $364 per box.

What is the latest price of imiglucerase in 2025?

Imiglucerase has been launched in China but has not been included in China's medical insurance. Currently, there is no generic version available on the market, and patients need to bear all the treatment costs themselves.

Price

Imiglucerase is developed and produced by Sanofi of France. The original research drug exported to Turkey, with a specification of 400U/10ml, is priced at approximately $364 per box. The above price is for reference only, and patients can choose to purchase according to their own situation.

Analysis of factors affecting prices

The price of imiglucerase is affected by many factors. Production cost is one of the important factors determining drug prices, including costs of raw materials, research and development, production, and quality control. The relationship between market demand and supply is also a key factor affecting prices. If market demand increases while supply is insufficient, prices tend to rise.

Purchasing channels for imiglucerase

For patients in need of purchasing imiglucerase, understanding the purchasing channels is crucial.

Hospital pharmacies

Hospital pharmacies are one of the main channels for purchasing imiglucerase. Patients can purchase the required drugs at hospital pharmacies with a doctor's prescription. Hospital pharmacies usually have strict drug quality management and supply guarantee systems, enabling patients to buy safe and effective drugs.

Professional pharmacies

In addition to hospital pharmacies, some professional pharmacies also provide sales services for imiglucerase. These pharmacies usually establish cooperative relationships with drug manufacturers or distributors. Patients can consult doctors or pharmacy staff to learn detailed information about the drugs and make purchases.

Precautions for using imiglucerase

When using imiglucerase for treatment, patients need to pay attention to the following matters:

Before medication

Before using imiglucerase, patients need to understand information such as the drug's indications, dosage and administration, and adverse reactions, and use the drug under the guidance of a doctor. Patients also need to undergo necessary examinations, such as blood routine, liver and kidney function tests, to assess whether their physical condition is suitable for using imiglucerase.

During medication

During the medication period, patients need to strictly follow the doctor's prescription, and avoid increasing or decreasing the dosage or changing the medication method on their own. Patients also need to closely monitor changes in their physical condition. If they experience allergic reactions, chills, fever, or other uncomfortable symptoms, they should seek medical attention in time and inform the doctor about the medication situation.

After treatment with imiglucerase, patients need to undergo regular re-examinations and follow-ups to evaluate the treatment effect and changes in their physical condition.